Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Income Tax Expense Over TimeContracting
Percentile Rank14
Studio
Year-over-Year Change

Income taxes paid or accrued

Percentile
P14
Within normal range
vs 3Y Ago
-9.8x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-5.28M-
2024$0.00+100.0%
2023$-1.80M-433.3%
2022$541000.00-
2021$0.00+100.0%
2020$-1.24M+83.3%
2019$-7.41M-2040.8%
2018$-346000.00-
2017$0.00-
2016$0.00-